Neuroone Medical Technologies Corp (NMTC)
$1.62
$-0.04
(-2.41%)
As on 04-Sep-2026 16:00EDT
Market cap
$15 Mln
Revenue (TTM)
$10 Mln
P/E Ratio
--
P/B Ratio
4.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
46.09
-
EV/EBITDA
-2.1
-
Debt to Equity
0
-
Book Value
$0.4
-
EPS
$-0.9
-
Face value
--
-
Shares outstanding
9,105,763
10 Years Aggregate
CFO
$-40.04 Mln
EBITDA
$-45.33 Mln
Net Profit
$-57.46 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Neuroone Medical Technologies Corp (NMTC)
| -64.4 | -4.7 | -53.3 | -63.7 | -32.3 | -43.6 | -- |
|
BSE Sensex*
| -9.9 | -3.3 | 2.8 | -5.4 | 5.0 | 5.5 | 10.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Neuroone Medical Technologies Corp (NMTC)
| -8.2 | -47.5 | 31.7 | -38.1 | 23.6 | -34.0 | -57.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Neuroone Medical Technologies Corp (NMTC)
|
1.6 | 14.8 | 10.0 | -7.2 | -71.5 | -140.6 | -- | 4.1 |
| 62.7 | 8,162.7 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.0 | |
| 15.0 | 10,125.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.8 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.4 | |
| 58.5 | 8,913.0 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 177.5 | 10,637.8 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 15.3 | |
| 101.0 | 6,590.6 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.2 | 5.0 | |
| 89.6 | 5,350.1 | 1,579.2 | 145.6 | 14.3 | 8.9 | 36.9 | 3.2 | |
| 322.2 | 12,649.5 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.3 | 8.3 | |
| 167.6 | 9,458.6 | 785.1 | 41.5 | 9.9 | 2 | 232.8 | 4.6 |
Shareholding Pattern
View DetailsAbout Neuroone Medical Technologies Corp (NMTC)
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for... spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota. Read more
-
President, CEO & Director
Mr. David A. Rosa M.D.
-
President, CEO & Director
Mr. David A. Rosa M.D.
-
Headquarters
Eden Prairie, MN
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Neuroone Medical Technologies Corp (NMTC)
What is the current share price of Neuroone Medical Technologies Corp (NMTC) Today?
The share price of Neuroone Medical Technologies Corp (NMTC) is $1.62 (NASDAQ) as of 04-Sep-2026 16:00 EDT. Neuroone Medical Technologies Corp (NMTC) has given a return of -32.3% in the last 3 years.
What is the current PB & PE ratio of Neuroone Medical Technologies Corp (NMTC)?
Since, TTM earnings of Neuroone Medical Technologies Corp (NMTC) is negative, P/E ratio is not available.
The P/B ratio of Neuroone Medical Technologies Corp (NMTC) is 4.06 times as on 04-Sep-2026, a 7 premium to its peers’ median range of 3.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.65 |
0.84 |
2024 |
-0.36 |
5.37 |
2023 |
-0.29 |
0.56 |
2022 |
-0.46 |
0.48 |
2021 |
-0.79 |
1.21 |
What is the 52 Week High and Low of Neuroone Medical Technologies Corp (NMTC)?
The 52-week high and low of Neuroone Medical Technologies Corp (NMTC) are Rs 6.96 and Rs 1.42 as of 07-Sep-2026.
What is the market cap of Neuroone Medical Technologies Corp (NMTC)?
Neuroone Medical Technologies Corp (NMTC) has a market capitalisation of $ 15 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Neuroone Medical Technologies Corp (NMTC)?
Before investing in Neuroone Medical Technologies Corp (NMTC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.